MENU
CGON
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
CG Oncology (CGON) Ownership - Who owns CG Oncology?
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer... Show more
Profile
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
61
Web
https://www.cgoncology.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
2.03B
P/E Ratio
N/A
Total Cash
540.71M
Projected Growth
N/A
Total Debt
296K
Revenue
684K
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.09
Total Debt/Equity
N/A
Revenue/Share
0.01 USD as % of share price
Fundamentals
CGON
Capitalization
2.03B
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
541M
Total Cash/Share
7.09
Total Debt
296K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.01%
Revenue
684K
ROE
N/A
Book Value
537M
P/B Ratio
2.88
Cash Flow
N/A
Earnings
-15.87
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
7K
Current Ratio
35.32
Current Revenue Per Employee
704.92
Dividends Per Share - Security
N/A
EBITDA
-95.94M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-20.60
Shares Held By Institutions
2.45B
Shares Outstanding - Current
76.2M
Total Liabilities
15.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-11.855
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
400 Spectrum Center Drive
Phone
+1 949 409-3700
Employees
61
Web
https://www.cgoncology.com